Rong-Rong HE

暨南大学教授、珠江学者特聘教授，国家杰青

Professor Rong-Rong He is the Vice Dean of TCM College and Associate Director in the Institute of Traditional Chinese Medicine and Natural Products, College of Pharmacy, Jinan University. She is an Associate Editor of Phytomedicine and Frontiers in Pharmacology, Editor of Chinese Medicine, BMC Cancer and Journal of Natural Medicines, etc. She was selected for the National Science Foundation for Distinguished Young Scholars (2021), National Science Foundation for Excellent Young Scientists of China (2016) and other talent projects. Her research interests focus on stress increases the disease susceptibility by inducing oxidative stress and chronic inflammation. The crosstalk lipid peroxidation and inflammatory lipid mediators have been long associated with many different kinds of diseases through yet not well characterized specific mechanisms. The research performed by Prof. He’s lab uncovers specific pathways and key enzymatic targets of oxidative lipid metabolism, providing new insights into mechanisms of cell death of neurons and immune cells. Based on those discoveries, Prof.He’s lab effectively discloses the pharmacological activities and mechanisms of TCM formula and herbs. She has published more than 100+ SCI papers in international high-level journals, such as Nat Chem Biol, Nat Commun, Redox Biol, etc. This series of novel research projects are supported by dozens of funding sources such as National Natural Science Foundation of China, Key Research Items from the Ministry of Science and Technology of China, and Major New Drug Creation program of the Ministry of Science and Technology. She has been granted 20+ patents, including one of which was awarded the 17th China Patent Excellence Award by the China National Intellectual Property Administration as the first complete person. Her scientific research achievements have won many government science and technology awards, such as the China Youth Science and Technology Award, First Prize of Guangdong Province Science and Technology Progress Award, the Second Prize of Science and Technology Progress of Higher Education Institutions of the Ministry of Education, the Ding Ying Science and Technology Award of Guangdong Province, the Guangdong Youth May Fourth Medal and other awards. Meanwhile, the results of one innovative research was selected as one of the top ten advances in Chinese medicine in 2021. In recent 3 years, her personal academic impact was selected for the Top 2% of Global Scientists lists jointly published by Stanford University and Elsevier Publishing Group.

Juyan Liu

Chief Engineer and Vice General Manager, Guangzhou Pharmaceutical Holdings Ltd. (GPHL)

Ms.Liu Juyan completed her postgraduate education and holds a doctorate degree in medicine; she is a senior engineer with the rank of professor. Ms. Liu began her career in 1990 and is currently chief engineer of GPHL, the largest pharmaceutical manufacturer in China. Ms. Liu was honored by serving as the National March eighth flag bearer and was recognized as a Guangzhou 121 reserved talent and as a Guangzhou Outstanding City Management Expert, among other awards. She has extensive experience in scientific research and development, technological research, and quality management.

Wei Yue

Senior Editor, FORTUNE China

Yue joined FORTUNE China in 2019. Before joining FORTUNE China, he was a Journalist for China Newsweek and Editor of China Times. In 2003, Yue graduated from Lanzhou University.

Daihan Zhou

National TCM Masters, Director of Tumor Institute of Guangzhou University of Chinese Medicine, Director of Shenzhen TCM Oncology Medical Center

Professor Dai-Han Zhou, a famous oncologist of traditional Chinese medicine, whose one of the third group of “National TCM Masters”, and as the director of Tumor Institute of Guangzhou University of Chinese Medicine, a chief professor, doctoral supervisor, and chief physician in Oncology Department of the First Affiliated Hospital of Guangzhou University of Chinese Medicine, President of Guangdong Association of Research and Promoting Traditional Chinese Medicine, Director of Shenzhen TCM Oncology Medical Center, the chief editor of the “Journal of Oncology in Chinese Medicine”, an excellent TCM physician of Guangdong province, an academician with Chinese Academy of Traditional Chinese Medicine.He is one of the founders of modern TCM oncology, who has expanded the connotation of clinical four diagnosis of tumor in TCM, proposed that the standard of Syndrome Differentiation and Treatment Administration for cancer patients began with “Shanghan Zabing Lun (Treatise on Cold Pathogenic and Miscellaneous Diseases）”, expand the connotation of “the four methods of diagnosis” and “Syndrome Differentiation Treatment” in clinical cancer therapeutics, and interpret the concepts of “people-oriented” and “survival with tumor”; He has developed the first Chinese patent medicine “HeChan Tablet” for treating lung cancer in China.He has compiled ten monographs, including “Summary of Tumor Treatment”, “Dietotherapy of Traditional Chinese Medical Oncology”, “Summary of clinical experience in tumor treatment”, and “Traditional Chinese Medical Oncology”.He won five provincial and ministerial level awards, including “Second Prize for Major Scientific Research Achievements Issued by the Ministry of Health”, “First Prize for Scientific and Technological Achievements Issued by the Ministry of Education”, and “Second Prize of Science and Technology Award issued by Guangdong Province”.He was granted amounts of honorary titles, like “a top role model worker of Nanyue (Guangdong) ”.In 2019, he won the “National Outstanding Contribution Award of Traditional Chinese Medicine”.Professor Zhou is the initiator of TCM oncology academic school in Lingnan region (Southern China), who started and promoted the higher education of TCM oncology, and supervised the publication of the first nationally planned TCM oncology textbook of the Ministry of Education.He has developed academic exchanges and cancer consultation in Hong Kong, Macao, Taiwan, Southeast Asia, the United States and Canada, and other countries.He is expert in the treatment of liver cancer, lung cancer, colon cancer and other advanced malignant tumors, as well as the rehabilitation of various types of cancers.

Guowei Xuan

Master of traditional Chinese medicine, Member of the Faculty of the Chinese Academy of Chinese Medical Sciences, and a chief professor and doctoral supervisor of Guangzhou University of Chinese Medicine

Xuan Guowei is a master of traditional Chinese medicine, a member of the Faculty of the Chinese Academy of Chinese Medical Sciences, an expert enjoying the special government allowance of the State Council, and a chief professor and doctoral supervisor of Guangzhou University of Chinese Medicine. Consultant of Dermatology Branch of Chinese Association of Chinese Medicine, Honorary President of Guangdong Association of Traditional Chinese Medicine, and leading medical talent in Guangdong Province. The second, third and fifth batches of academic experience inheritance instructors of old Chinese medicine experts in China, and the first batch of postdoctoral cooperative supervisors of Chinese medicine inheritance. He has won the National Outstanding Contribution Award of Traditional Chinese Medicine and the titles of "Harmonious China's Top Ten Health Guards". He has been practicing medicine for 60 years, with superb academic and remarkable curative effects, and is known as the "Holy Hand of Skin". In academic terms, he advocates the views of "leveling yin and yang, curing diseases", "detoxifying and driving away evil spirits, and cherishing peace". He is good at the diagnosis and treatment of skin diseases and difficult diseases such as disease loss, acne, urticaria, eczema, lupus erythematosus, etc. He has in-depth research on the theory of Chinese medicine kidney tonic method, and has achieved satisfactory results in the treatment of skin diseases and difficult diseases by applying kidney tonic method.